Ventavis FDA Approval History
FDA Approved: Yes (First approved December 29, 2004)
Brand name: Ventavis
Generic name: iloprost
Dosage form: Inhalation Solution
Company: CoTherix, Inc.
Treatment for: Pulmonary Arterial Hypertension
Ventavis (iloprost) inhalation solution is synthetic analogue of prostacyclin PGIB2B indicated for the treatment of pulmonary arterial hypertension.
Development timeline for Ventavis
|Dec 29, 2004||Approval Ventavis CoTherix, Inc. - Treatment for Pulmonary Arterial Hypertension|
|Sep 8, 2004||CoTherix, Inc. Announces Priority Review Designation by the FDA for Ventavis NDA|
|Jul 1, 2004||CoTherix, Inc. Announces Filing of Ventavis NDA|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.